Cargando…
Type 1 diabetes associated with immune checkpoint inhibitors for malignant melanoma: A case report and review of 8 cases
Advanced malignant melanoma (MM) is treated with immune checkpoint inhibitor (ICI) therapy, which often results in several immune-related adverse events. Fulminant type 1 diabetes mellitus (T1DM) is a rare, rapidly progressive, life-threatening disease. Here, we summarize 8 cases of MM with ICI-indu...
Autores principales: | Ishiguro, Akihiro, Ogata, Dai, Ohashi, Ken, Hiki, Kojiro, Yamakawa, Kohei, Jinnai, Shunichi, Tsutsui, Keita, Takahashi, Akira, Namikawa, Kenjiro, Yamazaki, Naoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439787/ https://www.ncbi.nlm.nih.gov/pubmed/36107581 http://dx.doi.org/10.1097/MD.0000000000030398 |
Ejemplares similares
-
Post-Immunotherapy Robotic-Assisted Resection for Primary Anorectal Melanoma: A Case Report
por: Tsutsui, Keita, et al.
Publicado: (2022) -
Targeted Therapy and Immunotherapy for Melanoma in Japan
por: Namikawa, Kenjiro, et al.
Publicado: (2019) -
Clonal dynamics of circulating tumor DNA during immune checkpoint blockade therapy for melanoma
por: Takai, Erina, et al.
Publicado: (2021) -
Intramedullary spinal cord metastasis of malignant melanoma:Two cases with rim signs in contrast-enhanced magnetic resonance imaging: A case report
por: Mizuta, Haruki, et al.
Publicado: (2021) -
Superficial Penile Leiomyosarcoma Mimicking a Benign Tumor
por: Haruki, Mizuta, et al.
Publicado: (2021)